Canopy Growth Corp APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Canopy Growth Corp (CGC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of CAD 1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was 1.36M CAD.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was 888.00K CAD, a 82.79% decline year-over-year.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was 2.01M CAD, a 61.52% decline year-over-year.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was -99.00K CAD, a 102.38% decline year-over-year.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was 4.27M CAD.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was -4.21M CAD, a 129.65% decline from fiscal 2024.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was 14.18M CAD, a 44.00% decline from fiscal 2023.
- Canopy Growth Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was 25.32M CAD, a 45.76% decline from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.36M CAD 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 4.27M CAD 10-K · filed 2026-06-15 | |||
| 2025-12-31 | 888.00K CAD 10-Q · filed 2026-02-06 | 2.90M CAD derived: sum of 2 quarters · filed 2026-02-06 | 2.80M CAD derived: sum of 3 quarters · filed 2026-08-07 | |
| 2025-09-30 | 2.01M CAD 10-Q · filed 2026-02-06 | 1.91M CAD derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2025-06-30 | -99.00K CAD 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | -4.21M CAD 10-K · filed 2026-06-15 | |||
| 2024-12-31 | 5.16M CAD 10-Q · filed 2026-02-06 | 10.38M CAD derived: sum of 2 quarters · filed 2026-02-06 | 14.53M CAD derived: sum of 3 quarters · filed 2026-02-06 | 18.58M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-09-30 | 5.22M CAD 10-Q · filed 2026-02-06 | 9.37M CAD derived: sum of 2 quarters · filed 2026-02-06 | 13.43M CAD derived: sum of 3 quarters · filed 2026-06-15 | 17.12M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-06-30 | 4.15M CAD 10-Q · filed 2026-02-06 | 8.20M CAD derived: sum of 2 quarters · filed 2026-06-15 | 11.90M CAD derived: sum of 3 quarters · filed 2026-06-15 | 14.62M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-03-31 | 4.05M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 7.75M CAD derived: sum of 2 quarters · filed 2026-06-15 | 10.46M CAD derived: sum of 3 quarters · filed 2026-06-15 | 14.18M CAD 10-K · filed 2026-06-15 |
| 2023-12-31 | 3.69M CAD 10-Q · filed 2025-02-07 | 6.41M CAD derived: sum of 2 quarters · filed 2025-02-07 | 10.13M CAD 10-Q · filed 2024-02-09 | 14.56M CAD derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-09-30 | 2.72M CAD 10-Q · filed 2025-02-07 | 6.43M CAD 10-Q · filed 2023-11-09 | 10.86M CAD derived: sum of 3 quarters · filed 2025-05-30 | 16.92M CAD derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-06-30 | 3.72M CAD 10-Q · filed 2025-02-07 | 8.15M CAD derived: sum of 2 quarters · filed 2025-05-30 | 14.20M CAD derived: sum of 3 quarters · filed 2025-05-30 | 23.77M CAD derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-03-31 | 4.43M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | 10.48M CAD derived: sum of 2 quarters · filed 2025-05-30 | 20.06M CAD derived: sum of 3 quarters · filed 2025-05-30 | 25.32M CAD 10-K · filed 2025-05-30 |
| 2022-12-31 | 6.05M CAD 10-Q · filed 2024-02-09 | 15.63M CAD derived: sum of 2 quarters · filed 2024-02-09 | 20.89M CAD 10-Q · filed 2024-02-09 | 32.41M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-09-30 | 9.57M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | 14.84M CAD 10-Q · filed 2023-11-09 | 26.35M CAD derived: sum of 3 quarters · filed 2024-05-30 | 32.97M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-06-30 | 5.26M CAD 10-Q · filed 2023-08-09 | 16.78M CAD derived: sum of 2 quarters · filed 2024-05-30 | 23.40M CAD derived: sum of 3 quarters · filed 2024-05-30 | 39.09M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-03-31 | 11.51M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | 18.13M CAD derived: sum of 2 quarters · filed 2024-05-30 | 33.83M CAD derived: sum of 3 quarters · filed 2024-05-30 | 46.69M CAD 10-K · filed 2024-05-30 |
| 2021-12-31 | 6.62M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 22.31M CAD derived: sum of 2 quarters · filed 2023-02-09 | 35.17M CAD 10-Q · filed 2023-02-09 | 53.25M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-09-30 | 15.69M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | 28.55M CAD 10-Q · filed 2022-11-09 | 46.63M CAD derived: sum of 3 quarters · filed 2023-06-22 | 65.96M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-06-30 | 12.86M CAD 10-Q · filed 2022-08-09 | 30.94M CAD derived: sum of 2 quarters · filed 2023-06-22 | 50.27M CAD derived: sum of 3 quarters · filed 2023-06-22 | 71.04M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-03-31 | 18.08M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 37.41M CAD derived: sum of 2 quarters · filed 2023-06-22 | 58.18M CAD derived: sum of 3 quarters · filed 2023-06-22 | 87.32M CAD 10-K · filed 2023-06-22 |
| 2020-12-31 | 19.33M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | 40.10M CAD derived: sum of 2 quarters · filed 2022-02-09 | 69.24M CAD 10-Q · filed 2022-02-09 | 146.68M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | 20.78M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | 49.92M CAD 10-Q · filed 2021-11-08 | 127.35M CAD derived: sum of 3 quarters · filed 2022-05-31 | 187.45M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-06-30 | 29.14M CAD 10-Q · filed 2021-08-06 | 106.58M CAD derived: sum of 2 quarters · filed 2022-05-31 | 166.67M CAD derived: sum of 3 quarters · filed 2022-05-31 | 257.30M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-03-31 | 77.44M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | 137.53M CAD derived: sum of 2 quarters · filed 2022-05-31 | 228.16M CAD derived: sum of 3 quarters · filed 2022-05-31 | 312.93M CAD 10-K · filed 2022-05-31 |
| 2019-12-31 | 60.10M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | 150.72M CAD derived: sum of 2 quarters · filed 2021-02-09 | 235.49M CAD 10-Q · filed 2021-02-09 | |
| 2019-09-30 | 90.63M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-09 | 175.40M CAD 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 84.77M CAD 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | 266.64M CAD 10-K · filed 2021-06-01 | |||
| 2018-03-31 | 47.60M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |